Form 13-F position report

COCRYSTAL PHARMA INC

Reported by TWO SIGMA SECURITIES LLC

COCP CUSIP 19188J409 Manager CIK 0001450144

Reported 0 shares, down 15,255 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2026
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 3 Through Q2 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2025-12-31 12484
2026-03-31 15408
2026-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

3 quarters
Quarterly reported position history for COCRYSTAL PHARMA INC held by TWO SIGMA SECURITIES LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Reduced 0 -15,255 (-100.0%) 0 $0 2026-08-14
Q1 2026 Added 15,255 +2,503 (19.6%) < 0.01% $15,408 2026-05-15
Q4 2025 New 12,752 +12,752 (0.0%) < 0.01% $12,484 2026-02-17

Who else reported the position

31 managers reported COCRYSTAL PHARMA INC for Q2 2026.

Managers reporting COCRYSTAL PHARMA INC in Q2 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD CAPITAL MANAGEMENT LLC Added 358,228 +118,257 < 0.01% $376,139 2 qtrs
RENAISSANCE TECHNOLOGIES LLC Added 179,628 +55,700 < 0.01% $188,609 15 qtrs
TWO SIGMA INVESTMENTS LP New 175,379 +175,379 < 0.01% $184,148 1 qtr
GEODE CAPITAL MANAGEMENT LLC Reduced 76,208 -14,023 < 0.01% $80,034 15 qtrs
BlackRock Inc Unchanged 73,746 0 < 0.01% $77,433 8 qtrs
CITADEL ADVISORS LLC New 45,118 +45,118 < 0.01% $47,374 1 qtr
Neuberger Berman Group LLC Unchanged 31,886 0 < 0.01% $33,480 6 qtrs
XTX Topco Ltd Reduced 29,342 -6,689 < 0.01% $30,809 3 qtrs
JANE STREET GROUP LLC Added 25,761 +13,050 < 0.01% $27,049 4 qtrs
VANGUARD FIDUCIARY TRUST CO Unchanged 24,016 0 < 0.01% $25,217 2 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2026
Filed
August 14, 2026
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.